Skip to main content

2024 National Biotechnology Conference Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

A
T1030-02-06
A Mechanistic Model of IgG4-RD Identifies High-Potential Therapy Targets

Favorite
T1130-02-10
A Novel Approach to Mechanical Characterization of Pharmaceutical Lyospheres

Favorite
T1430-02-10
A Novel In Vitro Serum Stability Assay for Antibody Therapeutics Incorporating Internal Standards

Favorite
T1230-02-07
A Validated Immunocapture LC-MS/MS Hybrid Assay for the Quantitation of a Novel Multi-Domain Therapeutic Protein in Human Plasma with Clinical Sample Analysis

Favorite
W1530-02-06
Age-Dependent Reduction in Hepatic Vector Genome Loss in Juvenile OTC^spf-ash Mice Following a Single Dose of DTX301 and Partial Compensation Achieved with a Higher Dose

Favorite
W1530-02-10
An “I” (Immunogenicity Risk Assessment) for an Eye (Ophthalmology Biologics)

Favorite
W1430-02-10
Analysis of Anti-Drug Antibodies (ADA) in Multiple Animal Species from mRNA LNP Therapeutics Supporting Rare Diseases Demonstrated Low Immunogenicity of PEG-2000 by ECLA and ELISA Methodology

Favorite
T1430-02-07
Analysis of Glucagon-Like Peptide-1 (GLP-1) Analog in Rat Plasma Using an LC-MS/MS Workflow

Favorite
T1030-02-07
Analytical Method Validation Strategy for Determination of Charge Heterogeneity of Antibody Therapeutics Using Reference Material Comparison as an Alternative to Spiking Studies

Favorite
W1030-02-06
Antibody Synthesis in Cell-Free for High-Throughput Production and Screening

Favorite
T1130-02-07
Anti-CCR8 Mediated Depletion of Tumor-Infiltrating Regulatory T Cells: Preclinical PK/PD and Translational Strategy in Support of Clinical Development for Solid Tumor Indications

Favorite
W1430-02-06
Application of a Novel Affinity Purified Chicken IgY in an Immunoaffinity LC-MS/MS Assay for Rapid Quantitation of Monoclonal Antibody Therapeutics and ADCs in Nonclinical Species

Favorite